News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
125,870 Results
Type
Article (5906)
Company Profile (21)
Press Release (119943)
Section
Business (30163)
Career Advice (275)
Deals (4926)
Drug Delivery (17)
Drug Development (21118)
Employer Resources (32)
FDA (4540)
Job Trends (3188)
News (62364)
Policy (7355)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Biotech Bay Standard (1)
2024 Biotech Beach Digital (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 Pharm Country Standard (1)
Academia (584)
Adcomms (9)
Allergies (17)
Alliances (9362)
ALS (27)
Alzheimer's disease (210)
Antibody-drug conjugate (ADC) (35)
Approvals (4562)
Artificial intelligence (80)
Autoimmune disease (1)
Automation (5)
Bankruptcy (25)
Best Places to Work (3134)
BIOSECURE Act (1)
Biosimilars (19)
Biotechnology (14)
Bladder cancer (34)
Brain cancer (18)
Breast cancer (124)
Cancer (846)
Cardiovascular disease (47)
Career advice (235)
Career pathing (2)
CAR-T (42)
Cell therapy (111)
Cervical cancer (8)
Clinical research (18393)
Collaboration (203)
Compensation (51)
Complete response letters (2)
COVID-19 (570)
CRISPR (8)
C-suite (29)
Cystic fibrosis (18)
Data (729)
Denatured (1)
Depression (9)
Diabetes (68)
Diagnostics (1913)
Digital health (4)
Diversity (1)
Diversity, equity & inclusion (10)
Drug discovery (27)
Drug pricing (9)
Drug shortages (1)
Duchenne muscular dystrophy (26)
Earnings (13276)
Editorial (4)
Employer branding (4)
Employer resources (29)
Events (15437)
Executive appointments (116)
FDA (4948)
Featured Employer (6)
Funding (149)
Gene editing (20)
Generative AI (6)
Gene therapy (63)
GLP-1 (126)
Government (865)
Grass and pollen (1)
Guidances (16)
Healthcare (4337)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (17)
Indications (11)
Infectious disease (606)
Inflammatory bowel disease (22)
Inflation Reduction Act (2)
Influenza (14)
Intellectual property (14)
Interviews (50)
IPO (2389)
IRA (1)
Job creations (241)
Job search strategy (185)
Kidney cancer (4)
Labor market (2)
Layoffs (33)
Leadership (2)
Legal (837)
Liver cancer (33)
Lung cancer (133)
Lymphoma (73)
Management (13)
Manufacturing (67)
MASH (6)
Medical device (3744)
Medtech (3746)
Mergers & acquisitions (2699)
Metabolic disorders (127)
Multiple sclerosis (8)
NASH (5)
Neurodegenerative disease (19)
Neuropsychiatric disorders (7)
Neuroscience (308)
NextGen: Class of 2025 (1116)
Non-profit (830)
Northern California (687)
Now hiring (1)
Obesity (51)
Opinion (49)
Ovarian cancer (35)
Pain (16)
Pancreatic cancer (28)
Parkinson's disease (19)
Partnered (7)
Patents (39)
Patient recruitment (35)
Peanut (7)
People (6297)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5099)
Phase II (8007)
Phase III (6933)
Pipeline (316)
Podcasts (1)
Policy (7)
Postmarket research (642)
Preclinical (1409)
Press Release (9)
Prostate cancer (36)
Psychedelics (9)
Radiopharmaceuticals (66)
Rare diseases (72)
Real estate (843)
Recruiting (12)
Regulatory (6245)
Reports (11)
Research institute (596)
Resumes & cover letters (49)
Rett syndrome (2)
RSV (3)
Schizophrenia (12)
Series A (28)
Series B (16)
Service/supplier (1)
Sickle cell disease (6)
Southern California (503)
Special edition (1)
Spinal muscular atrophy (24)
Sponsored (10)
Startups (432)
State (2)
Stomach cancer (3)
Supply chain (15)
United States (5310)
Vaccines (119)
Venture capitalists (4)
Webinars (1)
Weight loss (24)
Women's health (7)
Worklife (1)
Date
Today (26)
Last 7 days (169)
Last 30 days (664)
Last 365 days (9033)
2025 (2072)
2024 (9312)
2023 (9784)
2022 (10734)
2021 (10956)
2020 (10861)
2019 (9912)
2018 (7554)
2017 (6707)
2016 (6105)
2015 (6752)
2014 (4401)
2013 (3706)
2012 (4028)
2011 (4208)
2010 (3705)
Location
Africa (107)
Alabama (19)
Alaska (3)
Arizona (29)
Arkansas (2)
Asia (8208)
Australia (1458)
California (1466)
Canada (448)
China (165)
Colorado (87)
Connecticut (57)
Delaware (55)
Europe (19470)
Florida (219)
Georgia (27)
Idaho (13)
Illinois (112)
India (5)
Indiana (70)
Japan (32)
Kansas (30)
Kentucky (9)
Maine (10)
Maryland (179)
Massachusetts (992)
Michigan (54)
Minnesota (77)
Mississippi (1)
Missouri (19)
Montana (5)
Nebraska (6)
Nevada (12)
New Hampshire (26)
New Jersey (508)
New Mexico (11)
New York (397)
North Carolina (228)
North Dakota (3)
Northern California (687)
Ohio (37)
Oklahoma (4)
Oregon (7)
Pennsylvania (267)
Puerto Rico (4)
Rhode Island (5)
South America (175)
South Carolina (5)
Southern California (503)
Tennessee (21)
Texas (201)
Utah (33)
Virginia (40)
Washington D.C. (13)
Washington State (87)
West Virginia (1)
Wisconsin (17)
125,870 Results for "standard biotools".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Standard BioTools to Participate in Upcoming March 2025 Investor Conferences
February 28, 2025
·
1 min read
Press Releases
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
·
24 min read
Biotech Bay
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that its management team will participate in the following investor conferences in the month of June.
May 22, 2024
·
2 min read
Press Releases
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
January 14, 2025
·
5 min read
Press Releases
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025
February 12, 2025
·
1 min read
Press Releases
Standard BioTools to Participate in Upcoming Investor Conferences
October 31, 2024
·
1 min read
Press Releases
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine
January 9, 2025
·
7 min read
Business
Standard BioTools Reports First Quarter 2024 Financial Results
Standard BioTools Inc. announced financial results for the first quarter ended March 31, 2024 and recent business updates.
May 8, 2024
·
19 min read
Press Releases
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
·
1 min read
Press Releases
Standard BioTools Appoints Alex Kim as Chief Financial Officer
November 8, 2024
·
2 min read
1 of 12,587
Next
